Viewing data from:

IPRATROPIUM BROMIDE

ANDA

IPRATROPIUM BROMIDE | A075562 | NEPHRON CORP

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 8 NDCs

Highest NADAC/Unit

$0.1147

per ml

Lowest NADAC/Unit

$0.1080

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00487980101IPRATROPIUM BR 0.02% SOLN	$0.1147	ML	Generic	—	2026-06-17
00487980130IPRATROPIUM BR 0.02% SOLN	$0.1147	ML	Generic	—	2026-06-17
62135083084IPRATROPIUM BR 0.02% SOLN	$0.1147	ML	Generic	—	2026-06-17
64980064003IPRATROPIUM BR 0.02% SOLN	$0.1147	ML	Generic	—	2026-06-17
64980064006IPRATROPIUM BR 0.02% SOLN	$0.1128	ML	Generic	—	2026-06-17
00487980160IPRATROPIUM BR 0.02% SOLN	$0.1128	ML	Generic	—	2026-06-17
00487980125IPRATROPIUM BR 0.02% SOLN	$0.1080	ML	Generic	—	2026-06-17
64980064002IPRATROPIUM BR 0.02% SOLN	$0.1080	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

OLON SPAIPRATROPIUM BROMIDE

DMF 89731991

LUSOCHIMICA SPAIPRATROPIUM BROMIDE

DMF 89791991

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGIPRATROPIUM BROMIDE MONOHYDRATE

DMF 142591999

NEULAND LABORATORIES LTDIPRATROPIUM BROMIDE USP

DMF 151302000

AARTI PHARMALABS LTDIPRATROPIUM BROMIDE

DMF 211792007

AMPHASTAR NANJING PHARMACEUTICALS INCIPRATROPIUM BROMIDE USP

DMF 310362017

SCL LIFESCIENCES LTDIPRATROPIUM BROMIDE USP

DMF 379412025

DERIVADOS QUIMICOS SA FINE CHEMICALSInactiveIPRATROPIUM BROMIDE

DMF 231352009

CIPLA LTDInactiveIPRATROPIUM BROMIDE USP

DMF 298432015

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 14, 2003	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.02%

0 patents0 exclusivities▴

SOLUTION;INHALATION | Approved: Sep 27, 2001

No patent or exclusivity listings for this strength.